What not to do when choosing a CRO partner.
There are five common mistakes pharmaceutical, biotech, and medical device companies make when selecting a CRO to conduct a clinical study. You want a real partnership with your CRO based on facts versus perception. Making any one of the following five mistakes could have a negative impact on your clinical study.
Brenda Reese, RN
Going with a company you've always used "just because"
Pharmaceutical, biotech, and medical device companies face new competitive, regulatory, and economic challenges. Instead of automatically assigning new studies to the CRO you've always used, try a new approach. If you're looking for a different result and you're using the same CRO, it's time to try something new. The best CROs will welcome the challenge of addressing how they can help you conduct a faster, safer, compliant clinical study.
Going with a big name CRO because it is a safe choice
When it comes to choosing a CRO, size matters. Small to mid-sized sponsors might think it's a prudent decision to award their study to a large CRO because of the resources available to them. However, a small sponsor company is unlikely to get a large CRO's "A Team" because most large CROs assign their top people to their largest clients."
Mistaking therapeutic experience with study management expertise
Sponsors want CROs with relevant experience in their indications, but therapeutic experience does not guarantee study management expertise and high quality data delivered. Avoid the pitfall of putting therapeutic experience above study management expertise or past success in other clinical studies. A good study manager will deliver a successful study with or without the therapeutic experience.
Choosing a CRO based on the lowest bid
We get what we pay for. Going with the lowest bid can lead to numerous changes of scope, which can blow up your budget. Make sure the CRO bids your project thoroughly, including all aspects of running a study. Ask the CRO to anticipate changes to the number of sites and study design and have them provide sample cost estimates in the proposal. Most CROs will just provide an hourly rate. An hourly rate needs to include an estimate of the hours required to complete the task. Most studies will have changes and knowing some of them up front will save you money down the road. A good CRO will plan for changes of scope and include the sample costs in the original bid.
Getting caught in a bait-and-switch
Choose the CRO that will staff the best team for your study. Every CRO is likely to propose its best team for your study, but will you really get them? Months can pass between awarding and beginning a study. Do not base your decision on CVs and study personnel submitted during the bidding phase because you have no control over whether those submitted will still be employed at the CRO or available for your study when it begins. Ask for the track record of the study manager assigned to your project. How many studies have they started and completed in the past two years?
Brenda Reese, RN is Executive Director of West Coast Operations at DSP Clinical Research email: brenda@dspclinical.com
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.